Pharmacology in Exercise
Our first mission is to understand how physical exercise transforms pharmacological responses at the molecular level (Pk during exercise). We develop human experimental models across therapeutic and performance-enhancing drug domains, working toward solving the fundamental mechanisms of drug-exercise interactions.
Drugs and Health in Exercise
Our second mission is to understand how exercise-induced molecular mechanisms can improve quality of life in patients undergoing pharmacological treatment. We develop human experimental models to provide evidence-based answers on the clinical benefits of physical exercise in the presence of active pharmacotherapy (e.g., oncology, pain management).
Addiction in Exercise
Our third mission is to decode the molecular mechanisms by which exercise may function as an adjuvant intervention for substance and behavioral addictions in patients and athletes. We develop human experimental models to assess the benefits and risks of physical exercise in addiction treatment settings.